With chronic urticaria on the rise, the CURE study calls for greater awareness on guideline-recommended classification, diagnostic workup, and treatment.

Patients with CSU have an elevated risk of anxiety and depression, necessitating comprehensive management strategies. Research is focused on identifying biomarkers and clinical characteristics to ...

Chronic urticaria (CU) is a dermatological condition characterized by recurrent wheals (hives), angioedema (deep tissue swelling), or both, persisting for over 6 weeks. 1 Unlike acute urticaria, which ...

Urticarial vasculitis is an autoimmune condition that causes itchy or painful hives. Some people may also develop inflammation in other organs, such as the kidneys or lungs. Vasculitis is a group of ...

Lupus and hives sometimes go together, but only in about 10% of lupus cases. Lupus is a chronic autoimmune disease with a ...

Remibrutinib, a BTK inhibitor, offers a new oral treatment for chronic spontaneous urticaria, providing an alternative to traditional therapies. Experts discuss groundbreaking therapies in dermatology ...

Enter food therapy—a gentle, empowering approach that harnesses the power of everyday edibles to address root causes like ...

EAST HANOVER, N.J., Sept. 30, 2025 /PRNewswire/ -- Novartis announced today that Rhapsido ® (remibrutinib) received US Food and Drug Administration (FDA) approval as an oral treatment for adult ...

For most people, cold weather is an inconvenience, requiring an extra layer of clothing or the thermostat to be turned up. For others, exposure to cold can trigger an allergic reaction severe enough ...

The "Chronic Inducible Urticaria Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.